| Project | Program | Modality | Indication | Phase |
| RV001 | Undisclosed | Autologous CAR-T | Undisclosed | Preclinical |
| RV011 | Undisclosed | Allogenic CAR-T | Undisclosed | Preclinical |
| RV101 | Undisclosed | Autologous CAR-T | Undisclosed | Preclinical |
A CAR-T Cell Therapy Company
| Project | Program | Modality | Indication | Phase |
| RV001 | Undisclosed | Autologous CAR-T | Undisclosed | Preclinical |
| RV011 | Undisclosed | Allogenic CAR-T | Undisclosed | Preclinical |
| RV101 | Undisclosed | Autologous CAR-T | Undisclosed | Preclinical |